According to a research conducted by P&S Intelligence, the global HIV diagnosis market is projected to advance at a significant rate in the years to come. As the name suggests, HIV diagnosis is utilized for referring to test that is performed for detecting the presence of HIV in humans. If HIV is not treated, the patient may then suffer from acquired immunodeficiency syndrome (AIDS), the advanced stage of HIV infection, and not everyone suffering from HIV has AIDS. Governments across various countries are increasingly taking initiatives for raising awareness about blood transfusions and blood donations, which is further leading to the rising number of HIV diagnosis.
Key organizations, including International Federation of Red Cross and Red Crescent Societies, the World Health Organization (WHO), and the American Red Cross, have supported blood donor programs and have worked towards encouraging more people to donate blood components and blood. In addition to this, such associations and initiatives has led to the increased blood collections via voluntary donation across the globe. As per the WHO, in 2014, about 108 million blood donations were done across the globe.
The emergence of point-of-care instruments and kits for diagnosing HIV infection is further leading to increasing number of diagnostic tests. These tests have various advantages of conventional laboratory testing. Other than all this, the spending on HIV and other related activities has also been increasing in a number of countries. This is specially leading to the rising demand for HIV testing in developing countries. Different types of products that are utilized for testing HIV are instruments, consumables, and services and software. Out of these, the demand for consumables has been the highest in the past. Consumables include reagents, kits, and assays.
Kits are available as convenient and complete packed test systems and consist of a standard operating procedure. The patient need to follow instructions carefully for getting desired results. These products are easy to use and provide rapid, reliable, and sensitive detection of HIV. The major end users which make use of these products are hospitals, diagnostic laboratories, and research laboratories. Diagnostic laboratories have been dominating the HIV diagnosis market up till now. Some other end users are home care settings, cell banks, biotechnology and pharmaceutical companies, and gene banks.
Hence, the market is being driven by the surging prevalence of HIV and increasing government initiatives.
